Skip to content

Clinical trials

Neurobehavioral Manifestations trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurobehavioral Manifestations Country / region: Canada Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20151
20182
20192
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting1
Suspended1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre for Addiction and Mental Health1
Lundbeck Canada Inc.1
Marie-Josée Brouillette1
Nova Mentis Life Science Corp1
Sunnybrook Health Sciences Centre1
University of Alberta1
University of Calgary1
University of California, Davis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurobehavioral Manifestations8
Nervous System Diseases4
Fragile X Syndrome3
Chromosome Disorders2
Cognitive Dysfunction2
Confusion2
Congenital Abnormalities2
Delirium2
Genetic Diseases, X-Linked2
Intellectual Disability2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.